A multicenter study to determine the efficacy and safety of strontium ( 89Sr) chloride for palliation of painful bony metastases in cancer patients

Nippon Acta Radiologica

Volumn 65, Issue 4, 2005, Pages 399-410

  Nishio, Masamichi ^a   Sano, Muneaki ^b   Tamaki, Yoshio ^c   Fujii, Hirofumi ^d   Shima, Yasuo ^e   Fujimoto, Hiroyuki ^f   Kubo, Atsushi ^g   Koizumi, Kiyoshi ^h   Tokuda, Yutaka ⁱ   Adachi, Shuji ^j   Sumiyoshi, Yoshiteru ^k   Hasegawa, Toshihiro ^l   Eguchi, Kenji ⁱ  

^a HOKKAIDO CANCER CENTER   (Japan)

^b NIIGATA CANCER CENTER HOSPITAL   (Japan)

^c GUNMA PREFECTURAL CANCER CENTER   (Japan)

^d TOCHIGI CANCER CENTER   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g KEIO UNIVERSITY   (Japan)

^h TOKYO MEDICAL UNIVERSITY   (Japan)

ⁱ TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^k Department of Urology

^l NATIONAL KYUSHU CANCER CENTER   (Japan)

more..

Author keywords

Multicenter trial; Painful bone metastasis; QOL; Strontium ( 89Sr) chloride; VAS

Indexed keywords

STRONTIUM; STRONTIUM CHLORIDE;

ADULT; AGED; ARTICLE; BONE TUMOR; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; INTRACTABLE PAIN; MALE; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE TUMOR; QUALITY OF LIFE;

ADULT; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, INTRACTABLE; PALLIATIVE CARE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; STRONTIUM;

EID: 28844452118     PISSN: 00480428     EISSN: 13477951     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 2 incorporation into type I collagen during bone mineralization. J Nucl Med 41: 183-188, 2000
2. 2: potential relevance to the mechanism of action in pain palliation. Eur J Cancer 37: 2464-2469, 2001
3. Hoskin PJ: Scientific and clinical aspects of radiotherapy in the relief of bone pain. Cancer Surv 7: 69-86, 1988
4. th ed, 2720, 2001, Lippincott Williams & Wilkins, Philadelphia
5. Robinson RG, Preston DF, Schiefelbein M, et al: Strontium 89 therapy for the palliation of pain due to osseous metastases. JAMA 274 (5): 420-4, 1995
6. 89Sr] palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 27: 954-958, 1991
7. Bolger JJ, Dearnaley DP, Kirk D, et al: Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostate cancer; preliminary report of a multicentre trial. Semin Oncol 20(3 Suppl 2): 32-33, 1993
8. Jacox A, Carr DB, Payne R, et al: Management of cancer pain. Clinical practice guideline No. 9. AHCPR publication No. 94-0592. Rockville, MD. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, March 1994
9. Uki J, Mendoza T, Cleeland CS, et al: A brief cancer pain assessment tool in Japanese: The utility of the Japanese brief pain inventory B BPI-J. J Pain Symptom Manage 16: 364-373, 1988
10. Cella DF, Tulsky DS, Gray G, et al: The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 11 (3): 570-579, 1993
11. Agency for Health Care Policy and Research Clinical Good Practice Guideline
12. Anderson Cancer Center's guideline for treatment of cancer pain
13. David Cella: FACIT MANUAL, Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System Version 4. 1997, Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University
14. Clinical Safety Data Management: Definitions and standards and expedited reporting ICH harmonized tripartite guideline. 27 October 1994, ICH Steering Committee
15. Hiraga K, Ohashi Y: Efficacy evaluation of analgesic agents used for cancer pain management by visual analogue scale. Pain Research 14: 9-19, 1999
16. Radioisotopes 44: 123-134, 1995
17. 89Sr therapy for painful bone metastases from prostate cancer: A randomized clinical trial. J Nucl Med 43: 79-86, 2002
18. Tu SM, Millikan RE, Mengistu B, et al: Bone targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet 357: 336-41, 2001
19. Akerley W, Butera J, Wehbe T, et al: A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone. Cancer 94: 1654-1660, 2002
20. The EANM Radionuclide Therapy Committee: Guidelines for treatment of refractory metastatic bone pain (Last amended 15.02.2002)
21. Silberstein EB, Buscombe JR, McEwan A, et al: Society of nuclear medicine procedure guideline for palliative treatment of painful bone metastases. Ver. 3, 2003
22. 89Sr] Chloride SMS.2P) Technical Information, 2001
23. Medi-Physics Inc., Amersham Healthcare, Metastron (Strontium-89 Chloride Injection SMS.2PA), 1998
24. Bolger JJ, Deanaley DP, Kirk D, et al: Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. Semin Oncol 20 Suppl 2, 32-33, 1993
25. Porter T, McEwan AJ: Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: Results of a radomized controlled trial. Semin Oncol 20 Suppl 2, 38-43, 1993
26. McEwan AJ, Amyotte GA, McGowan DG, et al: A retrospective analysis of the cost effectiveness of treatment with Metastron in patients with prostate cancer metastatic to bone. Eur Urol 26 Suppl 1: 26-31, 1994
27. Hillner BE, Ingle JN, Chlebowski RT, et al: American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21: 4042-4057, 2003
28. Baczyk M, Baczyk E, Sowinski J: Preliminary results of combined application of radioisotopes and biphosphonates in the management of pain associated with osteoblastic-osteolytic bone metastases of breast cancer. Ortopedia Traumatologia Rehabilitacja 5: 234-237, 2003